While economic data may be scarce, every data point gives a new angle to the ever-uncertain economic conditions in the US.

Merck’s cancer immunotherapy Keytruda is the drug industry’s biggest blockbuster, bringing in $25 billion in sales last year. For years drug companies have sought to beat the therapy to no avail.

Forza Horizon 5 takes car lovers and fanatics on a road trip across Mexico, spanning harsh deserts and lush rainforests. Playground Games has delivered its most ambitious and advanced entry yet ...

AbbVie is a Dividend King with solid growth prospects. Merck's looming patent cliff isn't as alarming as it might seem. Pfizer offers a high dividend yield and lots of upside potential.

Merck (NYSE: MRK) is a top pharmaceutical company coming off a good quarter that shows it is growing its top and bottom lines. Even with that growth, the stock still trades at a fairly modest ...

Merck's business is growing, but the stock's gains have been modest this year. The drug manufacturer remains heavily reliant on Keytruda, which accounts for nearly half of its revenue. Merck has ...

Were we far apart on my offer and their asking price? Of course. It's a car purcahse. But in 5 minutes (or less), the General Manager Tim Rodgers and I reached an agreement equitable to both.

Merck faces significant challenges, including increased competition and regulatory scrutiny for Keytruda. Keytruda is facing potential threats from competitors like Summit Therapeutics ...

Cars aren’t as cheap as they used to be. Even a fairly basic family hatchback costs upwards of £25,000 – and you won’t get much change from three times that if you want a luxury SUV.

New car buyers to benefit as UAE market sees price stability and even bigger incentives New car sales in the UAE have surged in the first six months of 2024, helped by a mix of hyper competitive ...